These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 7996716)

  • 41. Disk prediffusion is a reliable method for testing colistin susceptibility in porcine E. coli strains.
    Boyen F; Vangroenweghe F; Butaye P; De Graef E; Castryck F; Heylen P; Vanrobaeys M; Haesebrouck F
    Vet Microbiol; 2010 Aug; 144(3-4):359-62. PubMed ID: 20172663
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories.
    Matuschek E; Brown DF; Kahlmeter G
    Clin Microbiol Infect; 2014 Apr; 20(4):O255-66. PubMed ID: 24131428
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical laboratory approach to estimate effective administrative dose of minocyclin. Reevaluation of in vitro MIC break points in disc susceptibility test].
    Uete G; Matsuo K; Uete T
    Jpn J Antibiot; 1990 Sep; 43(9):1545-58. PubMed ID: 2262962
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Susceptibility test methods which may be able to predict the emergence of resistance to newer beta- lactam antibiotics.
    Jorgensen JH
    Chemioterapia; 1985 Feb; 4(1):7-13. PubMed ID: 3986946
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of antimicrobial susceptibility testing of bacterial mixtures using agar dilution technique.
    Athar MA
    Am J Med Technol; 1980 Feb; 46(2):85-90. PubMed ID: 6986770
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the beta lactam disk for rapid detection of penicillinase producing bacteria: comparison with three other methods.
    Qadri SM; Smith JC; Mihm L
    Zentralbl Bakteriol A; 1981; 249(2):247-53. PubMed ID: 7023128
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antimicrobial susceptibility testing of Kingella kingae with broth microdilution and disk diffusion using EUCAST recommended media.
    Matuschek E; Åhman J; Kahlmeter G; Yagupsky P
    Clin Microbiol Infect; 2018 Apr; 24(4):396-401. PubMed ID: 28760709
    [TBL] [Abstract][Full Text] [Related]  

  • 48. BSAC standardized disc susceptibility testing method (version 10).
    Andrews JM; Howe RA;
    J Antimicrob Chemother; 2011 Dec; 66(12):2726-57. PubMed ID: 21921076
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Techniques for anaerobic susceptibility testing.
    Thornsberry C
    J Infect Dis; 1977 Mar; 135 Suppl():S4-6. PubMed ID: 850089
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical laboratory approach for estimating effective administrative dose of tobramycin. Reevaluation of in vitro MIC break points of disk susceptibility test].
    Uete G; Matsuo K; Uete T
    Jpn J Antibiot; 1989 Sep; 42(9):1888-99. PubMed ID: 2810752
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Setting interpretive breakpoints for antimicrobial susceptibility testing using disk diffusion.
    Kronvall G; Giske CG; Kahlmeter G
    Int J Antimicrob Agents; 2011 Oct; 38(4):281-90. PubMed ID: 21640560
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical laboratory approach to evaluate efficacy of amikacin. Reevaluation of in vitro MIC break points in disc susceptibility test].
    Uete G; Matsuo K; Uete T
    Jpn J Antibiot; 1992 May; 45(5):489-501. PubMed ID: 1512934
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New concepts in antimicrobial susceptibility testing: the mutant prevention concentration and mutant selection window approach.
    Blondeau JM
    Vet Dermatol; 2009 Oct; 20(5-6):383-96. PubMed ID: 20178475
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Routine determination of Neisseria gonorrhoeae susceptibility to antibiotics by a disk diffusion method (author's transl)].
    Pinon G; Laudat P
    Ann Biol Clin (Paris); 1981; 39(5):279-84. PubMed ID: 6797333
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Susceptibility testing for bovine respiratory and enteric disease.
    Apley MD
    Vet Clin North Am Food Anim Pract; 2003 Nov; 19(3):625-46. PubMed ID: 14608804
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Comparison of MICs of new quinolones obtained using agar-dilution and broth-microdilution procedures].
    Iwasaki H; Tsuji A; Kaneko Y; Goto S
    Jpn J Antibiot; 1995 Mar; 48(3):389-401. PubMed ID: 7752452
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Determination of sensitivity of rapid growing bacteria by the MS-2-system. A comparison with conventional methods (author's transl)].
    Wiebe C; Linzenmeier G
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Dec; 251(2):237-47. PubMed ID: 7200305
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical laboratory approach for determination of effective dose of cefotiam. Observation from disc susceptibility test and MICs].
    Uete T; Tsuzaki Y; Furukawa S; Matsuo K
    Jpn J Antibiot; 1982 Jun; 35(6):1441-61. PubMed ID: 6290707
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [In vitro investigations of rifampicin. Correlation between minimal inhibitory concentration and minimal inhibitory zone].
    Grimm H
    Arzneimittelforschung; 1978; 28(5):735-8. PubMed ID: 581953
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interpretive criteria for the agar diffusion susceptibility test with ofloxacin.
    Grimm H
    Drugs; 1987; 34 Suppl 1():14-9. PubMed ID: 3481315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.